New Model Adviser - For professional financial planners

Register for full access to Citywire’s Fund Manager database, news and analysis. Registration is free and only takes a minute.
6545.27 + 79 1.23% 04:35

Artemis Income

Citywire Selection Verdict:  As part of their strategy, Adrian Frost and Adrian Gosden have a talent for selecting overseas companies and make full use of their maximum 20% global allocation which gives them exposure to large international pharmaceuticals. The duo remain overweight in healthcare and keep faith with UK listed majors GlaxoSmithKline and AstraZeneca. They have reduced positions in media and basic resources to make way for a top ten positon in the personal and household goods sector. The fund has shown it performs well in both good and bad markets and has delivered consistent returns. A sound pick in this space.

For more information view the latest Artemis Income R Incfund factsheet.

Leave a comment!

Please sign in or register to comment. It is free to register and only takes a minute or two.